Cargando…

Cell-Based Delivery of Interleukin-13 Directs Alternative Activation of Macrophages Resulting in Improved Functional Outcome after Spinal Cord Injury

The therapeutic effects of mesenchymal stem cell (MSC) transplantation following spinal cord injury (SCI) to date have been limited. Therefore, we aimed to enhance the immunomodulatory properties of MSCs via continuous secretion of the anti-inflammatory cytokine interleukin-13 (IL-13). By using MSCs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dooley, Dearbhaile, Lemmens, Evi, Vangansewinkel, Tim, Le Blon, Debbie, Hoornaert, Chloé, Ponsaerts, Peter, Hendrix, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161742/ https://www.ncbi.nlm.nih.gov/pubmed/27974221 http://dx.doi.org/10.1016/j.stemcr.2016.11.005

Ejemplares similares

Interleukin-25 is detrimental for recovery after spinal cord injury in mice
por: Dooley, Dearbhaile, et al.
Publicado: (2016)

Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
por: Van Broeckhoven, Jana, et al.
Publicado: (2022)

Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model
por: Le Blon, Debbie, et al.
Publicado: (2016)

Mouse mast cell protease 4 suppresses scar formation after traumatic spinal cord injury
por: Vangansewinkel, Tim, et al.
Publicado: (2019)

HDAC3 Inhibition Promotes Alternative Activation of Macrophages but Does Not Affect Functional Recovery after Spinal Cord Injury
por: Sanchez, Selien, et al.
Publicado: (2018)

Targeted intracerebral delivery of the anti-inflammatory cytokine IL13 promotes alternative activation of both microglia and macrophages after stroke
por: Hamzei Taj, Somayyeh, et al.
Publicado: (2018)

Concise Review: Innate and Adaptive Immune Recognition of Allogeneic and Xenogeneic Cell Transplants in the Central Nervous System
por: Hoornaert, Chloé J., et al.
Publicado: (2017)

ADAM17 is a survival factor for microglial cells in vitro and in vivo after spinal cord injury in mice
por: Vidal, P M, et al.
Publicado: (2013)

Tackling the physiological barriers for successful mesenchymal stem cell transplantation into the central nervous system
por: De Vocht, Nathalie, et al.
Publicado: (2013)

Spatiotemporal evolution of early innate immune responses triggered by neural stem cell grafting
por: Reekmans, Kristien, et al.
Publicado: (2012)

Effects of Recombinant IL-13 Treatment on Gut Microbiota Composition and Functional Recovery after Hemisection Spinal Cord Injury in Mice
por: Hamad, Ibrahim, et al.
Publicado: (2023)

Interleukin-1 participates in the classical and alternative activation of microglia/macrophages after spinal cord injury
por: Sato, Atsushi, et al.
Publicado: (2012)

HDAC8 Inhibition Reduces Lesional Iba-1+ Cell Infiltration after Spinal Cord Injury without Effects on Functional Recovery
por: Hendrix, Sven, et al.
Publicado: (2020)

Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury
por: Amo-Aparicio, Jesus, et al.
Publicado: (2021)

Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice
por: Guerrero, Alexander Rodriguez, et al.
Publicado: (2012)

L-Arginine Depletion Improves Spinal Cord Injury via Immunomodulation and Nitric Oxide Reduction
por: Erens, Céline, et al.
Publicado: (2022)

Oxidative DNA Damage in the Pathophysiology of Spinal Cord Injury: Seems Obvious, but Where Is the Evidence?
por: Scheijen, Elle E. M., et al.
Publicado: (2022)

Neuroprotective effects of interleukin 10 in spinal cord injury
por: Li, Juan, et al.
Publicado: (2023)

Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury
por: Zhang, Bei, et al.
Publicado: (2015)

Interleukin-10 genetically modified clinical-grade mesenchymal stromal cells markedly reinforced functional recovery after spinal cord injury via directing alternative activation of macrophages
por: Gao, Tianyun, et al.
Publicado: (2022)

Antibody profiling identifies novel antigenic targets in spinal cord injury patients
por: Palmers, Ilse, et al.
Publicado: (2016)

The Pro-Inflammatory Cytokine, Interleukin-6, Enhances the Polarization of Alternatively Activated Macrophages
por: Fernando, Maria Ruweka, et al.
Publicado: (2014)

Absence of IL-1β positively affects neurological outcome, lesion development and axonal plasticity after spinal cord injury
por: Boato, Francesco, et al.
Publicado: (2013)

Interleukin-13, but Not Indomethacin, Increases Cysteinyl-Leukotriene Synthesis in Human Lung Macrophages
por: Jackson, Sarah E., et al.
Publicado: (2012)

Evaluation of the effects of erythropoietin and interleukin-6 in rats submitted to acute spinal cord injury
por: de Barros, Alderico Girão Campos, et al.
Publicado: (2019)

Pathological Anatomy of the Brain, Spinal Cord, and Their Membranes, with 13 Coloured Plates
Publicado: (1831)

Sexuality Support After Spinal Cord Injury: What is Provided in Australian Practice Settings?: Sexuality Support After Spinal Cord Injury
por: Bryant, Chloe, et al.
Publicado: (2022)

Function of microglia and macrophages in secondary damage after spinal cord injury
por: Zhou, Xiang, et al.
Publicado: (2014)

Hematogenous Macrophages: A New Therapeutic Target for Spinal Cord Injury
por: Ding, Yuanzhe, et al.
Publicado: (2021)

Low-level laser facilitates alternatively activated macrophage/microglia polarization and promotes functional recovery after crush spinal cord injury in rats
por: Song, Ji Wei, et al.
Publicado: (2017)

Astroglial TLR9 antagonism promotes chemotaxis and alternative activation of macrophages via modulation of astrocyte-derived signals: implications for spinal cord injury
por: Li, Lun, et al.
Publicado: (2020)

Serotonergic modulation of post-synaptic inhibition and locomotor alternating pattern in the spinal cord
por: Gackière, Florian, et al.
Publicado: (2014)

Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models
por: Nack, Anne, et al.
Publicado: (2019)

Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation
Publicado: (1992)

Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype
por: Cardilo-Reis, Larissa, et al.
Publicado: (2012)

Macrophage MSR1 promotes the formation of foamy macrophage and neuronal apoptosis after spinal cord injury
por: Kong, Fan-Qi, et al.
Publicado: (2020)

Systemic Interleukin-4 Administration after Spinal Cord Injury Modulates Inflammation and Promotes Neuroprotection
por: Lima, Rui, et al.
Publicado: (2017)

Neuroglobin Expression Models as a Tool to Study Its Function
por: Luyckx, Evi, et al.
Publicado: (2019)

Incidence of spinal cord injuries in Germany
por: Rau, Yannick, et al.
Publicado: (2022)

Managing Inflammation after Spinal Cord Injury through Manipulation of Macrophage Function
por: Ren, Yi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k7j67771i3pf7ma2sj5u1j9q5j